Mursla Bio collaborates with a leading global pharma company to advance biomarker-guided precision medicine in MASH

Mursla Bio’s AI Precision Medicine Platform to inform drug development and patient stratification in metabolic liver disease

Shift Bioscience publishes improved metric calibration framework for robust genetic perturbation modeling using AI Virtual Cells

AI virtual cells outperform key baselines on well-calibrated metrics, challenging prior reports of poor model performance Foundational research reinforces the use of virtual

TRIMTECH Therapeutics appoints Dr Mike Hutton to Scientific Advisory Board

·       Industry leader brings deep expertise across neurodegenerative disease therapeutics development ·       Dr Hutton joins Prof. Alessio Ciulli FRS and Dr Adam Gilbert on SAB

SPT Labtech and Alithea Genomics collaborate to automate ultra sensitive single-cell transcriptomic workflows

Integrates Alithea Genomics’ MERCURIUS FLASH-seq single-cell RNA-seq protocol with SPT Labtech’s firefly liquid handling platform Enables higher-throughput, cost efficient single-cell sequencing

Cambridge, UK, and Lausanne, Switzerland, 05 Novem

Optibrium delivers real-time collaboration in its comprehensive molecular design platform with StarDrop 8

Latest release accelerates hit-to-candidate progression by keeping teams aligned, eliminating inefficiencies and enabling better prioritisation decisions

VALANX Biotech appoints Klaus Orlinger, PhD. as Chief Scientific Officer

Strategic hire of industry expert bolsters leadership team as Company progresses first antibody drug conjugate to candidate selection phaseAppointment will drive development of VALANX’ GoldenSite™ platform to advance development of best-in-class therapeutic protein conj

ProImmune Ltd introduces ProVE® SL Self-Loading MHC Class I Monomers to improve T cell research flexibility

Oxford, UK – 30 October 2025 – ProImmune Ltd, a global leader in life science reagents and services, announces the launch of its new ProVE® SL Self-Loading MHC Class I Monomers.

Qureight’s Vascul8 model validated to improve care for pulmonary vascular disorders

Study published in ‘American Journal of Respiratory Cell and Molecular Biology’ validates Qureight’s deep-learning models and imaging platform beyond fibrotic lung disease, into new therapeutic areas for severe respiratory diseaseData demonstrate sensitive quantificatio

OMED Health Partners with Aviva to support the digestive health of employees

75 Aviva employees to gain pilot access to doctor-led OMED Health Plans, which include the use of the OMED Health Breath Analyzer and mobile appCollaboration will evaluate the impact of the OMED solution on the digestive health and quality of life of participants in a w

Biodesix announces expanded Bio-Rad Laboratories partnership agreement to develop Droplet Digital™ PCR High Complexity Assays

Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer testing

ProImmune expands into new 18,000 sq ft global headquarters enabling major expansion in immunology and life science innovation

Move follows ProImmune’s recent acquisition of Oasis Park a 70,000 sq ft Business and Light Industrial Park in Oxford, UKIncreased operational capacity enables accelerated development of ProImmune’s REVEAL® Immunogenicity System and Ankyron® target

Bio-Rad’s iQ-Check Enterobacteriaceae Kit validated for detection of Enterobacteriaceae in infant formula and cereals

Certified by MicroVal for Detection of Enterobacteriaceae Including Salmonella, Cronobacter, and E.coli as Indicator of Process Effectiveness to Eliminate Contaminants in Infant Formula and Related Ingredients.

Enamine contributes to the discovery of promising broad-spectrum coronavirus antiviral

Open-science research initiative, COVID Moonshot and the AI-driven Structure-enabled Antiviral Platform (ASAP) consortium, delivered a promising pre-clinical candidate2,000 new compounds generated for the programme are now available from Enamine’s catalogue

Mosaic Therapeutics appoints Thomas Fuchs as CEO

Former CEO of Cimeio Therapeutics, and Global Haematology Franchise Head at Roche-Genentech, brings extensive track record of strategic and operational leadershipAppointment strengthens executive leadership team and supports transition into clinical development

giles introduces AI agent to accelerate healthcare and life science research

AI tool connects researchers to verified medical and life sciences global databases, enabling accurate extraction and summarisation of academic papers, journals, and articlesgiles will be showcased at ISPOR Europe 2025, Glasgow, 9-12th November, booth 314

Cyclana Bio raises £5M to advance drug discovery for Endometriosis

Co-led by NfX and Eka VC, investors include Cocoa VC, Wilbe, and Angel investorsInvestment will support development of whole tissue-based platform for identification of druggable targets and scaling of observational clinical trial

Cambridge, UK,

SPT Labtech and 10x Genomics partner to automate single cell workflows

Automated workflows will be highlighted at ASHG 2025 with customer-generated dataPartnership to enable automated workflows for 10x Genomics’ Chromium Single Cell Platform on SPT Labtech’s firefly liquid handling platform

Melbourn, UK, and Pleasa

CN Bio launches all-in-one Organ-on-a-chip system, PhysioMimix® Core

Combines single-organ, multi-organ, and higher-throughput configurations within one scalable platformFully compatible with existing PhysioMimix accessories, validated protocols, consumables, and organ model kits for seamless workflow integration 

FairJourney Biologics appoints Dr. Werner Lanthaler as Chief Executive Officer

Dr.

SPT Labtech and Agilent introduce automated target enrichment protocols for genomic workflows

Optimized, automated protocols on SPT Labtech’s firefly®+ using Agilent’s SureSelect Max DNA Library Prep KitSupports high-throughput sequencing in clinical research, oncology, and precision medicineProtocols to be showcased at ASHG, 14th –

Five leading life science organisations collaborate on inaugural London Bio-Innovation Week

ELRIG, Life Science Integrates, Life Science Nation, One Nucleus and SLAS will provide delegates with the opportunity for cross-event partnering during London B

Bio-Rad extends partnership with Gencurix through strategic agreement for Droplet Digital™ PCR IVD Oncology Kits in Europe

Extended Partnership Agreement Will Expand Availability Across Europe of Gencurix’ In Vitro Diagnostic (IVD) Assays Using Droplet Digital™ PCR (ddPCR™) for Clinical Testing of Critical Oncology Biomarkers

Tagomics publishes a new approach to genome-wide epigenomic profiling

Study published in ‘Cell Reports Methods’ demonstrates the strength of Tagomics’ platform for epigenomic biomarker discovery and applications in liquid biopsyActivace platform enables targeted, genome-wide profiling of unmethylated DNA regions, providing a comprehensive

Miebach Consulting doubles footprint on Abingdon Science Park

Bespoke facilities within The Science Quadrant offer additional capacity as part of ongoing growth

SynGenSys introduces NK.SET synthetic promoter library to advance natural killer cell therapies

First commercially available NK (natural killer) cell-specific promoter library enables precise and controllable gene expressionPortfolio of synthetic promoters validates SynGenSys’ platform for engineering targeted, tissue-specific gene regulation control elements